Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and α(v)β3 integrins

Circulation

Volumn 98, Issue 11, 1998, Pages 1085-1091

  Tam, Susan H ^a   Sassoli, Patricia M ^a   Jordan, Robert E ^a   Nakada, Marian T ^a  

^a CENTOCOR INC   (United States)

Author keywords

Antibodies; Glycoproteins; Platelet aggregation inhibitors

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR; INTEGRIN;

ARTICLE; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RESTENOSIS; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; THROMBOSIS PREVENTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0032530659     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.11.1085     Document Type: Article

References (34)

1. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994;330:956-961.
2. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 1997;336:1689-1696.
3. The CAPTURE Investigators. Randomized placebo-controlled trial of abciximab before and during intervention in refractory unstable angina: the CAPTURE study. Lancet. 1997;349:1429-1435.
4. Charo IF, Bekeart LS, Phillips DR. Platelet glycoprotein IIb-IIIa-like proteins mediate endothelial cell attachment to adhesive proteins and the extracellular matrix. J Biol Chem. 1987;262:9935-9938.
5. Coller BS, Cheresh DA, Asch E, Seligsohn U. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood. 1991;77:75-83.
6. Rodan SB, Rodan GA. Integrin function in osteoclasts. J Endocrinol. 1997;154:547-556.
7. 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci U S A. 1994;91:8856-8860.
8. Conforti G, Dominquez-Jimenez C, Zanetti A, Gimbrone MA Jr, Cremona O, Marchisio PC, Dejana E. Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood. 1992; 80:437-446.
9. 3 Integrin expression in normal and atherosclerotic artery. Circ Res. 1995; 77:1129-1135.
10. 3 for angiogenesis. Science. 1994;264:569-571.
11. 3 on vascular cells during wound repair. Am J Pathol. 1996;148:1407-1421.
12. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J Clin Invest. 1995;95: 713-724.
13. Reverter JC, Béguin S, Kessels H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. J Clin Invest. 1996;98: 863-874.
14. Sugihara K, Sugihara T, Mohandas N, Hebbel RP. Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood. 1992;80:2634-2642.
15. Zanetti A, Conforti G, Hess S, Martin-Padura I, Ghibaudi E, Preissner KT, Dejana E. Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membrane. Blood. 1994;84:1116-1123.
16. 3) mediates platelet adhesion to the luminal aspect of endothelial cells. Circulation. 1997;96: 1809-1818.
17. Varner JA, Nakada M, Jordan R, Coller B. Anti-angiogenic properties of 7E3, an integrin β3 subunit antagonist, in the SCID mouse-human skin model of human angiogenesis. Thromb Haemost. 1997;90(suppl):158. Abstract.
18. Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE. Analysis of GP IIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood. 1996;88:907-914.
19. 3 involves a discrete cation-binding site that regulates conformation. J Biol Chem. 1996;271:1364-1370.
20. 3 on vascular cells. Blood. 1997;90:286. Abstract.
21. 3 on platelets and lymphocytes binds to the matrix protein osteopontin. J Biol Chem. 1997;272:8137-8140.
22. Marchisio PC, Bondanza S, Cremona O, Cancedda R, DeLuca M. Polarized expression of integrin receptors and their relationship with cytoskeleton and basement membrane matrix in culture human keratinocytes. J Cell Biol. 1991;112:761-773.
23. 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells. J Cell Biol. 1991;113:451-461.
24. Plow EF, Loftus JC, Levin EG, Fair DS, Dixon D, Forsyth J, Ginsberg NH. Immunologic relationship between platelet membrane GP IIb/IIIa and cell surface molecule expressed by a variety of cells. Proc Natl Acad Sci U S A. 1986;83:6002-6006.
25. Coller BS. Activation affects access to the platelet receptor for adhesive glycoproteins. J Cell Biol. 1986;103:451-456.
26. 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J Cell Biol. 1991;113:919-929.
27. Christopoulos C, Mackie I, Lahiri I, Machin S. Flow cytometric observations on the in vivo use of Fab fragments of a chimeric monoclonal antibody to platelet glycoprotein IIb-IIIa. Blood Coagul Fibrinolysis. 1993;4:729-737.
28. Mascelli MA, Lance ET, Damaraju L, Wagner CL, Weisman HF, Jordan RE. Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade. Circulation. 1998;97:1680-1688.
29. Konstantopoulos K, Kamat SG, Schafer AI, Banez EI, Jordan R, Kleiman NS, Hellums JD. Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty. Circulation. 1995;91:1427-1431.
30. 3 and osteopontin expression during neointima formation. Cardiol Res. 1997;36:408-428.
31. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 1993;92:1686-1696.
32. 3. Blood. 1995;86:2606-2615.
33. Byzova TV, Plow EF. Networking in the hemostatic system. J Biol Chem. 1997;272:27183-27188.
34. Jordan RE, Wagner CL, Gray JW, Bhattacharya S, Sane DC, Machin SJ, Mackie I, Anderson KM, Mattis JA, Weisman HF. Molecular pharmacology of chimeric 7E3 monoclonal Fab fragment in human subjects: Plasma clearance and binding to platelet GP IIb/IIIa receptors. Blood. 1991;78:489A. Abstract.